These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 6966574

  • 21. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 22. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N.
    J Immunol; 1981 Jul 01; 127(1):34-8. PubMed ID: 7240748
    [Abstract] [Full Text] [Related]

  • 23. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K, Kano S, Takaku F, Okumura K.
    J Natl Cancer Inst; 1980 Dec 01; 65(6):1265-9. PubMed ID: 7001124
    [Abstract] [Full Text] [Related]

  • 24. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM.
    J Immunol; 1983 Sep 01; 131(3):1531-8. PubMed ID: 6309965
    [Abstract] [Full Text] [Related]

  • 25. A subpopulation of allospecific cytotoxic T-cell precursors with phenotypic characteristics of natural killer cells.
    Kaplan J, Wasserman K.
    Nat Immun Cell Growth Regul; 1985 Sep 01; 4(6):305-14. PubMed ID: 2418351
    [Abstract] [Full Text] [Related]

  • 26. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S, Naruo K, Ootsu K, Houkan T, Shiho O, Tsukamoto K.
    Immunology; 1987 Feb 01; 60(2):173-9. PubMed ID: 3493209
    [Abstract] [Full Text] [Related]

  • 27. Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice.
    Riccardi C, Migliorati G, Herberman RB.
    Nat Immun Cell Growth Regul; 1987 Feb 01; 3(1):7-21. PubMed ID: 6235449
    [Abstract] [Full Text] [Related]

  • 28. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 29. AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.
    Taniguchi K, Kawano YI, Nomoto K.
    Immunology; 1988 Aug 15; 64(4):669-76. PubMed ID: 2971609
    [Abstract] [Full Text] [Related]

  • 30. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 15; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 31. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr 15; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

  • 32. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 33. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA, Hiserodt JC, Abruzzo LV, Varani J.
    Cancer Res; 1986 Jul 01; 46(7):3407-12. PubMed ID: 2939945
    [Abstract] [Full Text] [Related]

  • 35. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL, Karjalainen HE, Tevethia SS.
    J Immunol; 1987 Feb 15; 138(4):1215-20. PubMed ID: 3027174
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of natural killer activity by calcitonin gene-related peptide.
    Umeda Y, Arisawa M.
    Immunopharmacol Immunotoxicol; 1989 Feb 15; 11(2-3):309-20. PubMed ID: 2559931
    [Abstract] [Full Text] [Related]

  • 37. A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.
    Miller VE, Lagarde AE, Longenecker BM, Greenberg AH.
    J Immunol; 1986 Apr 15; 136(8):2968-74. PubMed ID: 2420880
    [Abstract] [Full Text] [Related]

  • 38. Generation of natural killer cell lines from murine long-term bone marrow cultures.
    Yung YP, Okumura K, Moore MA.
    J Immunol; 1985 Mar 15; 134(3):1462-8. PubMed ID: 3968424
    [Abstract] [Full Text] [Related]

  • 39. Display of the neutral glycolipid ganglio-n-tetraosylceramide (asialo GM1) on cells of the natural killer and T lineages.
    Beck BN, Gillis S, Henney CS.
    Transplantation; 1982 Feb 15; 33(2):118-22. PubMed ID: 6977214
    [Abstract] [Full Text] [Related]

  • 40. Asialo-GM1+ natural killer cells directly suppress antibody-producing B cells.
    Robles CP, Pollack SB.
    Nat Immun Cell Growth Regul; 1989 Feb 15; 8(4):209-22. PubMed ID: 2797013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.